Broadcom
AVGO
Taiwan Semiconductor
TSM
Tesla
TSLA
ASML Holding
ASML
Qualcomm
QCOM
US Stock MarketDetailed Quotes
NKTX Nkarta
- 2.340
- +0.050+2.18%
Close Dec 13 16:00 ET
- 2.530
- +0.190+8.12%
Post 19:59 ET
165.13MMarket Cap-1.28P/E (TTM)
2.440High2.240Low3.35MVolume2.300Open2.290Pre Close7.97MTurnover7.64%Turnover RatioLossP/E (Static)70.57MShares16.24052wk High0.38P/B102.69MFloat Cap2.24052wk Low--Dividend TTM43.89MShs Float79.160Historical High--Div YieldTTM8.73%Amplitude1.280Historical Low2.378Avg Price1Lot Size
About Nkarta Company
Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The firm’s product include NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes, and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA.
Company Profile
SymbolNKTX
Company NameNkarta
Listing DateJul 10, 2020
Issue Price18.00
Founded2005
CEOMr. Paul J. Hastings
MarketNASDAQ
Employees150
Fiscal Year Ends12-31
Address1150 Veterans Boulevard
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-925-407-1049
Websitehttp://www.nkartatx.com
Company Executives
- Name
- Position
- Salary
- Paul J. Hastings
- Chief Executive Officer and Director
- 2.93M
- Alyssa Levin
- Chief Financial Officer, Chief Business Officer and Principal Accounting Officer
- 1.29M
- Dr. David R. Shook, M.D.
- Chief Medical Officer and Head of Research and Development
- 1.51M
- Dr. Ralph Brandenberger, PhD
- Chief Technical Officer
- --
- Dr. Alicia J. Hager, PhD
- Chief Legal Officer and Corporate Secretary
- --
- Dr. Ali Behbahani, M.B.A.,M.D.
- Chairman of the Board
- 166.75K
- Dr. Nadir Mahmood, PhD
- President
- --
- Leone D Patterson
- Independent Director
- 136.25K
- Dr. Zachary Scheiner, PhD
- Independent Director
- 125.25K
- Angela Thedinga
- Independent Director
- 122.50K
- Dr. Simeon J. George, M.B.A.,M.D.
- Independent Director
- 126.25K
- Dr. Michael Dybbs, PhD
- Independent Director
- 135.25K
- George Vratsanos, M.D.
- Independent Director
- --
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.